ATE224892T1 - Substituierte n-(piperidin-4-yl)-4h-3,1- benzo(thia/oxa)zin-2-amine, ihre herstellung und therapeutische verwendung - Google Patents

Substituierte n-(piperidin-4-yl)-4h-3,1- benzo(thia/oxa)zin-2-amine, ihre herstellung und therapeutische verwendung

Info

Publication number
ATE224892T1
ATE224892T1 AT00900639T AT00900639T ATE224892T1 AT E224892 T1 ATE224892 T1 AT E224892T1 AT 00900639 T AT00900639 T AT 00900639T AT 00900639 T AT00900639 T AT 00900639T AT E224892 T1 ATE224892 T1 AT E224892T1
Authority
AT
Austria
Prior art keywords
carbon atoms
branched
thia
oxa
benzo
Prior art date
Application number
AT00900639T
Other languages
English (en)
Inventor
Jean-Pierre Rieu
Jean-Francois Patoiseau
Gareth John
Bruno Legrand
Yvan Verscheure
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Application granted granted Critical
Publication of ATE224892T1 publication Critical patent/ATE224892T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT00900639T 1999-01-22 2000-01-21 Substituierte n-(piperidin-4-yl)-4h-3,1- benzo(thia/oxa)zin-2-amine, ihre herstellung und therapeutische verwendung ATE224892T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9900706A FR2788775B1 (fr) 1999-01-22 1999-01-22 Nouvelles n-alcoyl-n-[1-(omega-(arylalcoyloxy)alcoyl] piperidin-4-yl]-4h-3,1-benzo(thia/oxa)zines-2-amines substituees, leur preparation et leur application en therapeutique
PCT/FR2000/000137 WO2000043391A1 (fr) 1999-01-22 2000-01-21 1-(piperidin-4-yl)-3-(aryl)-isothiourees substituees, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
ATE224892T1 true ATE224892T1 (de) 2002-10-15

Family

ID=9541133

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00900639T ATE224892T1 (de) 1999-01-22 2000-01-21 Substituierte n-(piperidin-4-yl)-4h-3,1- benzo(thia/oxa)zin-2-amine, ihre herstellung und therapeutische verwendung

Country Status (15)

Country Link
US (1) US6531469B1 (de)
EP (1) EP1144408B1 (de)
JP (1) JP2002535329A (de)
CN (1) CN1129599C (de)
AT (1) ATE224892T1 (de)
AU (1) AU767132B2 (de)
BR (1) BR0007674A (de)
CA (1) CA2359103A1 (de)
DE (1) DE60000500T2 (de)
DK (1) DK1144408T3 (de)
ES (1) ES2182770T3 (de)
FR (1) FR2788775B1 (de)
PT (1) PT1144408E (de)
WO (1) WO2000043391A1 (de)
ZA (1) ZA200105921B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR900701170A (ko) * 1988-09-29 1990-12-01 클러런스 제이 모이에 육류보존법 및 육류보존 물질
EP0982300A3 (de) * 1998-07-29 2000-03-08 Societe Civile Bioprojet Alkylamine ohne Imidazolring als Histamin-H3-antagonisten und deren therapeutische Anwendung
FR2821356A1 (fr) * 2001-02-23 2002-08-30 Cerep Nouveaux derives d'arylcarbamates et d'arylurees, preparations et utilisations
FR3001151B1 (fr) 2013-01-21 2016-04-08 Pf Medicament Association d'un bloqueur de courant sodique lent et d'un inhibiteur du courant if sinusal et les compositions pharmarceutiques la contenant
KR102474467B1 (ko) 2013-03-14 2022-12-05 암젠 인크 복소환식 화합물 및 그들의 용도
CN114349745B (zh) * 2022-01-14 2023-12-08 黑龙江中医药大学 一种用于治疗心肌缺血的药物及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737207B1 (fr) * 1995-07-26 1997-10-17 Pf Medicament Nouvelles n-heterocyclyl-1-aryloxyalcoyl-4-piperidinamines substituees, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
ZA200105921B (en) 2002-05-08
JP2002535329A (ja) 2002-10-22
AU767132B2 (en) 2003-10-30
FR2788775A1 (fr) 2000-07-28
FR2788775B1 (fr) 2001-04-13
PT1144408E (pt) 2003-02-28
DK1144408T3 (da) 2003-02-03
EP1144408A1 (de) 2001-10-17
DE60000500T2 (de) 2003-07-31
BR0007674A (pt) 2001-11-20
CN1344267A (zh) 2002-04-10
EP1144408B1 (de) 2002-09-25
US6531469B1 (en) 2003-03-11
DE60000500D1 (de) 2002-10-31
ES2182770T3 (es) 2003-03-16
CN1129599C (zh) 2003-12-03
AU3058100A (en) 2000-08-07
CA2359103A1 (fr) 2000-07-27
WO2000043391A1 (fr) 2000-07-27

Similar Documents

Publication Publication Date Title
DE60015927D1 (en) Phenylharnstoff und phenylthioharnstoffderivate
ID17851A (id) Persenyawaan heterosiklis, produksi dan pemakaiannya
MXPA00006605A (es) Compuestos de carbonil-indol biciclicos como agentes antiinflamatorios/analgesicos.
PE20010126A1 (es) Pirrolotriazinas como inhibidores de cinasas
FI941567A0 (fi) Bentso- ja pyridopyridatsinoni- ja -pyridatsiinitioniyhdisteet
PT870768E (pt) Derivados azaindole-etilamina como agentes de ligacao nicotinicos aos receptores de acetilcolina
BR9509629A (pt) Derivados de aminotetrazol úteis como inibidores de óxido nítrico sintase
EP1166781A4 (de) Proteasomhemmer
SE503618C2 (sv) Antihyperkolesterolemiska tetrazolföreningar
ATE224892T1 (de) Substituierte n-(piperidin-4-yl)-4h-3,1- benzo(thia/oxa)zin-2-amine, ihre herstellung und therapeutische verwendung
ES2110977T3 (es) Espiro-isoquinolein-pirrolidinas y analogos de las mismas, utiles como inhibidores de la aldosa-reductasa.
ATE412041T1 (de) 1,3,4-oxadiazole als additive für schmiermittel
IL66835A0 (en) Triazoloquinazolone derivatives and their salts,their preparation,their use as medicaments and the compositions containing them
FR2788771B1 (fr) Nouvelles 1,2-alcoyl-1-[1-[aryl (alcoyl) oxyalcoyl] piperidin-4-yl]-3-aryl isothiourees substituees, leur preparation et leur application en therapeutique
PE20011003A1 (es) Inhibidores de metaloproteasas
BR9813923A (pt) N n - bis(sulfonil) hidrazinas úteis como agentes antineoplásicos
EP1197211A4 (de) Wirkstoffe zur vorbeugung und behandlung von krebs
MX9601163A (es) Nuevos compuestos derivados de cromeno.
NO914577L (no) Fremgangsmaate for fremstilling av heterocyklisk substituerte piperazinoalkylbenzoksazin- og -tiazinforbindelser
PT1189908E (pt) Alcaloides de indolocarbazole de um actinomiceto marinho
TW366283B (en) Compounds for treatment of arrhythmia
ES2096628T3 (es) Derivados heterociclicos.
DK141282A (da) Fremgangsmaade til fremstilling af morpholiner
SE8302076L (sv) Nya imidazolkinoxaliner och deras salter, framstellning derav, anvendning derav sasom lekemedel, kompositioner innehallande dem och de erhallna mellanprodukterna
FR2826005B1 (fr) Synthese totale de la galanthamine, de ses analogues et de ses derives

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1144408

Country of ref document: EP

REN Ceased due to non-payment of the annual fee